Naringenin inhibits adipogenesis and reduces insulin sensitivity and adiponectin expression in adipocytes

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Richard, Allison J ^a   Amini Vaughan, Zhaleh ^a   Ribnicky, David M ^b   Stephens, Jacqueline M ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; NARINGENIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; LIPID STORAGE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 84883199721     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/549750     Document Type: Article

References (45)

1. Hursting S. D., Hursting M. J., ATVB in focus: metabolic syndrome and insulin resistance: mechanisms and consequences. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 1766 1770 10.1161/ATVBAHA.111.241927
2. Nikolopoulou A., Kadoglou N. P., Obesity and metabolic syndrome as related to cardiovascular disease. Expert Review of Cardiovascular Therapy 2012 10 7 933 939 10.1586/erc.12.74
3. Danforth E. Jr., Failure of adipocyte differentiation causes type II diabetes mellitus? Nature Genetics 2000 26 1, article 13 10.1038/79111
4. Khan T., Muise E. S., Iyengar P., Wang Z. V., Chandalia M., Abate N., Zhang B. B., Bonaldo P., Chua S., Scherer P. E., Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Molecular and Cellular Biology 2009 29 6 1575 1591 2-s2.0-62849107819 10.1128/MCB.01300-08
5. Kim J. Y., van de Wall E., Laplante M., Azzara A., Trujillo M. E., Hofmann S. M., Schraw T., Durand J. L., Li H., Li G., Jelicks L. A., Mehler M. F., Hui D. Y., Deshaies Y., Shulman G. I., Schwartz G. J., Scherer P. E., Obesity-associated improvements in metabolic profile through expansion of adipose tissue. Journal of Clinical Investigation 2007 117 9 2621 2637 2-s2.0-34848872799 10.1172/JCI31021
6. Finkelstein E. A., Khavjou O. A., Thompson H., Trogdon J. G., Pan L., Sherry B., Dietz W., Obesity and severe obesity forecasts through 2030. The American Journal of Preventive Medicine 2012 42 6 563 570 10.1016/j.amepre.2011. 10.026
7. Pan S. Y., Zhou S. F., Gao S. H., Yu Z. L., Zhang S. F., Tang M. K., Sun J. N., Ma D. L., Han Y. F., Fong W. F., Ko K. M., New perspectives on how to discover drugs from herbal medicines: CAM's outstanding contribution to modern therapeutics. Evidence-Based Complementary and Alternative Medicine 2013 2013 25 627375 10.1155/2013/627375
8. Mulvihill E. E., Allister E. M., Sutherland B. G., Telford D. E., Sawyez C. G., Edwards J. Y., Markle J. M., Hegele R. A., Huff M. W., Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes 2009 58 10 2198 2210 2-s2.0-70349651441 10.2337/db09-0634
9. Ortiz-Andrade R. R., Sánchez-Salgado J. C., Navarrete- Vázquez G., Webster S. P., Binnie M., García-Jiménez S., León-Rivera I., Cigarroa-Vázquez P., Villalobos-Molina R., Estrada-Soto S., Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes, Obesity and Metabolism 2008 10 11 1097 1104 2-s2.0-54249141439 10.1111/j.1463-1326.2008.00869.x
10. Laemmli U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 227 5259 680 685 2-s2.0-0014949207 10.1038/227680a0
11. Schneider C. A., Rasband W. S., Eliceiri K. W., NIH image to ImageJ: 25 years of image analysis. Nature Methods 2012 9 671 675 10.1038/nmeth.2089
12. Kuri-Harcuch W., Green H., Adipose conversion of 3T3 cells depends on a serum factor. Proceedings of the National Academy of Sciences of the United States of America 1978 75 12 6107 6109 2-s2.0-0344993515
13. Stephens J. M., Pekala P. H., Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor- α The Journal of Biological Chemistry 1991 266 32 21839 21845 2-s2.0-0025837140
14. Harmon A. W., Harp J. B., Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. The American Journal of Physiology 2001 280 4 C807 C813 2-s2.0-0034996015
15. White M. F., IRS proteins and the common path to diabetes. The American Journal of Physiology 2002 283 3 E413 E422 10.1152/ajpendo.00514.2001
16. Ziemke F., Mantzoros C. S., Adiponectin in insulin resistance: lessons from translational research. The American Journal of Clinical Nutrition 2010 91 1 258S 261S 10.3945/ajcn.2009.28449C
17. MacDougald O. A., Lane M. D., Transcriptional regulation of gene expression during adipocyte differentiation. Annual Review of Biochemistry 1995 64 345 373 2-s2.0-0029062839
18. Scott R. E., Florine D. L., Wille J. J. Jr., Yun K., Coupling of growth arrest and differentiation at a distinct state in the G1 phase of the cell cycle: GD. Proceedings of the National Academy of Sciences of the United States of America 1982 79 3 845 849 10.1073/pnas.79.3.845
19. Tang Q. Q., Otto T. C., Lane M. D., Mitotic clonal expansion: a synchronous process required for adipogenesis. Proceedings of the National Academy of Sciences of the United States of America 2003 100 1 44 49 10.1073/pnas.0137044100
20. Claussnitzer M., Skurk T., Hauner H., Daniel H., Rist M. J., Effect of flavonoids on basal and insulin-stimulated 2-deoxyglucose uptake in adipocytes. Molecular Nutrition and Food Research 2011 55 supplement 1 S26 S34 2-s2.0-79957870751 10.1002/mnfr.201000372
21. Harmon A. W., Patel Y. M., Naringenin inhibits phosphoinositide 3-kinase activity and glucose uptake in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 2003 305 2 229 234 10.1016/S0006-291X(03)00720-4
22. Bae S. S., Cho H., Mu J., Birnbaum M. J., Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. The Journal of Biological Chemistry 2003 278 49 49530 49536 2-s2.0-1542781732
23. Borradaile N. M., de Dreu L. E., Huff M. W., Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation. Diabetes 2003 52 10 2554 2561 2-s2.0-0141643289 10.2337/diabetes.52.10.2554
24. Cheatham B., Vlahos C. J., Cheatham L., Wang L., Blenis J., Kahn C. R., Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Molecular and Cellular Biology 1994 14 7 4902 4911 2-s2.0-0028308412
25. Koiani K., Carozzi A. J., Sakaue H., Hara K., Robinson L. J., Clark S. F., Yonezawa K., James D. E., Kasuga M., Requirement for phosphoinositide 3-kinase in insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 1995 209 1 343 348 2-s2.0-0028903554 10.1006/bbrc.1995.1509
26. Sakaue H., Ogawa W., Takata M., Kuroda S., Kotani K., Matsumoto M., Sakaue M., Nishio S., Ueno H., Kasuga M., Phosphoinositide 3-kinase is required for insulin-induced but not for growth hormone- or hyperosmolarity-lnduced glucose uptake in 3T3-l1 adipocytes. Molecular Endocrinology 1997 11 10 1552 1562 2-s2.0-8544234984 10.1210/me.11.10.1552
27. Tanti J., Grémeaux T., Grillo S., Calleja V., Klippel A., Williams L. T., van Obberghen E., Marchand-Brustel Y. L., Overexpression of a constitutively active form of phosphatidylinositol 3-kinase is sufficient to promote Glut 4 translocation in adipocytes. The Journal of Biological Chemistry 1996 271 41 25227 25232 2-s2.0-0029795178 10.1074/jbc.271.41.25227
28. Lee Jongsoon L. J., Pilch P. F., The insulin receptor: structure, function, and signaling. The American Journal of Physiology 1994 266 2 C319 C334 2-s2.0-0027974563
29. White M. F., Kahn C. R., The insulin signaling system. The Journal of Biological Chemistry 1994 269 1 1 4
30. Goodyear L. J., Kahn B. B., Exercise, glucose transport, and insulin sensitivity. Annual Review of Medicine 1998 49 235 261 10.1146/annurev.med.49.1. 235
31. Abel E. D., Peroni O., Kim J. K., Kim Y., Boss O., Hadro E., Minnemann T., Shulman G. I., Kahn B. B., Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001 409 6821 729 733 2-s2.0-0035825643 10.1038/35055575
32. Koch C. E., Ganjam G. K., Steger J., Legler K., Stohr S., Schumacher D., Hoggard N., Heldmaier G., Tups A., The dietary flavonoids naringenin and quercetin acutely impair glucose metabolism in rodents possibly via inhibition of hypothalamic insulin signalling. The British Journal of Nutrition 2013 109 6 1040 1051 10.1017/S0007114512003005
33. Erlund I., Meririnne E., Alfthan G., Aro A., Human nutrition and metabolism: plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. Journal of Nutrition 2001 131 2 235 241 2-s2.0-0035150315
34. Assini J. M., Mulvihill E. E., Sutherland B. G., Telford D. E., Sawyez C. G., Felder S. L., Chhoker S., Edwards J. Y., Gros R., Huff M. W., Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr-/- mice. Journal of Lipid Research 2013 54 711 724 10.1194/jlr.M032631
35. Kannappan S., Anuradha C. V., Naringenin enhances insulin-stimulated tyrosine phosphorylation and improves the cellular actions of insulin in a dietary model of metabolic syndrome. European Journal of Nutrition 2010 49 2 101 109 10.1007/s00394-009-0054-6
36. Horiba T., Nishimura I., Nakai Y., Abe K., Sato R., Naringenin chalcone improves adipocyte functions by enhancing adiponectin production. Molecular and Cellular Endocrinology 2010 323 2 208 214 2-s2.0-77952944681 10.1016/j.mce.2010.03.020
37. Liu L., Shan S., Zhang K., Ning Z. Q., Lu X. P., Cheng Y. Y., Naringenin and hesperetin, two flavonoids derived from Citrus aurantium up-regulate transcription of adiponectin. Phytotherapy Research 2008 22 10 1400 1403 10.1002/ptr.2504
38. Felgines C., Texier O., Morand C., Manach C., Scalbert A., Régerat F., Rémésy C., Bioavailability of the flavanone naringenin and its glycosides in rats. The American Journal of Physiology 2000 279 6 G1148 G1154 2-s2.0-0033636972
39. Kanaze F. I., Bounartzi M. I., Georgarakis M., Niopas I., Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. European Journal of Clinical Nutrition 2007 61 4 472 477 2-s2.0-34247212317 10.1038/sj.ejcn.1602543
40. Choudhury R., Chowrimootoo G., Srai K., Debnam E., Rice-Evans C. A., Interactions of the flavonoid naringenin in the gastrointestinal tract and the influence of glycosylation. Biochemical and Biophysical Research Communications 1999 265 2 410 415 2-s2.0-0033584954 10.1006/bbrc.1999.1695
41. Zygmunt K., Faubert B., MacNeil J., Tsiani E., Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK. Biochemical and Biophysical Research Communications 2010 398 2 178 183 2-s2.0-77955052130 10.1016/j.bbrc.2010.06.048
42. Adeneye A. A., Methanol seed extract of Citrus paradisi Macfad lowers blood glucose, lipids and cardiovascular disease risk indices in normal Wistar rats. Nigerian Quarterly Journal of Hospital Medicine 2008 18 1 16 20
43. Deyhim F., Mandadi K., Patil B. S., Faraji B., Grapefruit pulp increases antioxidant status and improves bone quality in orchidectomized rats. Nutrition 2008 24 10 1039 1044 2-s2.0-50549100492 10.1016/j.nut.2008.05.005
44. Diaz-Juarez J. A., Tenorio-Lopez F. A., Zarco-Olvera G., Valle-Mondragon L. D., Torres-Narvaez J. C., Pastelin-Hernandez G., Effect of Citrus paradisi extract and juice on arterial pressure both in vitro and in vivo. Phytotherapy Research 2009 23 7 948 954 10.1002/ptr.2680
45. Oyelami O. A., Agbakwuru E. A., Adeyemi L. A., Adedeji G. B., The effectiveness of grapefruit (Citrus paradisi) seeds in treating urinary tract infections. Journal of Alternative and Complementary Medicine 2005 11 2 369 371 2-s2.0-18444364251 10.1089/acm.2005.11.369